Fulcrum BioEnergy was founded in 2007 by E. James Macias and James A. C. McDermott. After filing for an IPO in 2011, the company withdrew a year later, citing unfavorable market conditions. In January 2022, however, the company announced the appointment of a new CFO and VP. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Fulcrum BioEnergy is developing a commercially-viable process to convert municipal solid waste into zero-carbon transportation fuels. In May 2022, the company's Sierra Biorefinery commenced operations, becoming "the world's first landfill waste to renewable transportation fuels plant." The company has raised more than $260 million in venture capital funding from investors including SK Holdings, BP Ventures, Cathay Pacific Airways, United Airlines, Rustic Canyon Partners, and US Renewables. Fulcrum BioEnergy has not released public valuation statistics.
Fulcrum BioEnergy does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Fulcrum BioEnergy will be known as it becomes public. Here are similar public companies: First Solar (NAS: FSLR), Chevron (NYS: CVX), General Electric (NYS: GE).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 7/12/2022 | Series D-8 | $1.08B | $XXX.XX | $XXX.XX |
| 12/16/2021 | Series D-7-3, D-7-4, D-7-5, D-7-6, and D-7-7 | $940.56MM | $XXX.XX | $XXX.XX |
| 7/17/2020 | Series D-7-1 and D-7-2 | $881.74MM | $XXX.XX | $XXX.XX |
| 7/12/2019 | Series D-7 | $875.85MM | $XXX.XX | $XXX.XX |
| 9/19/2018 | Series D-6 | $798.12MM | $XXX.XX | $XXX.XX |
| 10/26/2017 | Series D-4, D-4-1, and D-5 | $701.88MM | $XXX.XX | $XXX.XX |
| 7/24/2017 | Series D-3 | $602.89MM | $XXX.XX | $XXX.XX |
| 11/8/2016 | Series D-2 | $537.17MM | $XXX.XX | $XXX.XX |
| 6/22/2015 | Series D-1 | $456.44MM | $XXX.XX | $XXX.XX |
| 2/15/2015 | Series D | $399.63MM | $XXX.XX | $XXX.XX |
| 8/7/2014 | Series C-3 | $413.88MM | $XXX.XX | $XXX.XX |
| 1/25/2011 | Series C-1 | $305.14MM | $XXX.XX | $XXX.XX |
| 6/23/2010 | Series B-2 | $113.97MM | $XXX.XX | $XXX.XX |
| 7/24/2008 | Series B-1 | $37.71MM | $XXX.XX | $XXX.XX |
| 8/9/2007 | Series A | $2.22MM | $XXX.XX | $XXX.XX |
Fulcrum BioEnergy is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
If you own Fulcrum BioEnergy pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Fulcrum BioEnergy is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
